Skip to content

Clinical trials

Phase 3 Neoplasms, Glandular and Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms, Glandular and Epithelial Phase: Phase 3 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20101
20141
20151
20162

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Sumitomo Pharma America, Inc.2
Abbott1
Guangxi Medical University1
Imunon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms, Glandular and Epithelial7
Digestive System Diseases4
Digestive System Neoplasms4
Neoplasms4
Neoplasms by Histologic Type4
Neoplasms by Site4
Adenocarcinoma3
Carcinoma, Hepatocellular3
Liver Neoplasms3
Carcinoma2

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.